The DOI matches its Crossref record; 217 of the 218 references it cites were found in a registry or an index.
Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Open accessAbstract
Parkinson’s disease (PD) is the second most common neurodegenerative disease characterized by motor dysfunction. Growing evidence has demonstrated that gut dysbiosis is involved in the occurrence, development and progression of PD. Numerous clinical trials have identified the characteristics of the changed gut microbiota profiles, and preclinical studies in PD animal models have indicated that gut dysbiosis can influence the progression and onset of PD via increasing intestinal permeability, aggravating neuroinflammation, aggregating abnormal levels of α-synuclein fibrils, increasing oxidative stress, and decreasing neurotransmitter production. The gut microbiota can be considered promising diagnostic and therapeutic targets for PD, which can be regulated by probiotics, psychobiotics, prebiotics, synbiotics, postbiotics, fecal microbiota transplantation, diet modifications, and Chinese medicine. This review summarizes the recent studies in PD-associated gut microbiota profiles and functions, the potential roles, and mechanisms of gut microbiota in PD, and gut microbiota-targeted interventions for PD. Deciphering the underlying roles and mechanisms of the PD-associated gut microbiota will help interpret the pathogenesis of PD from new perspectives and elucidate novel therapeutic strategies for PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“gut microbial dysbiosis not only leads to intestinal inflammation but also increases intestinal permeability.”
From Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson’s Disease (2023) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Tamtaji, O. R., Taghizadeh, M., Daneshvar Kakhaki, R., Kouchaki, E., Bahmani, F., Borzabadi, S., Oryan, S., Mafi, A., & Asemi, Z. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.05.018 · Cited by 398
RetractedRetracted: Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease
Heinzel, S., Aho, V. T. E., Suenkel, U., von Thaler, A., Schulte, C., Deuschle, C., Paulin, L., Hantunen, S., Brockmann, K., Eschweiler, G. W., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25788 · Cited by 95
RetractedLinking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J. P., Druart, C., Bindels, L. B., Guiot, Y., Derrien, M., Muccioli, G. G., Delzenne, N. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219451110 · Cited by 4,511
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Parada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00277 · Cited by 3,820
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
The role of short-chain fatty acids in microbiota–gut–brain communication
Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0157-3 · Cited by 3,357
Dorsey, E. R., Elbaz, A., Nichols, E., Abbasi, N., Abd-Allah, F., Abdelalim, A., Adsuar, J. C., Ansha, M. G., Brayne, C., Choi, J.-Y. J., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30295-3 · Cited by 2,816
Flagged first, then by citations
1 of the 218 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The gut microbiota–brain axis in neurological disorder
Ullah, H., Arbab, S., Tian, Y., Liu, C., Chen, Y., Li, Q., Khan, M. I. U., Hassan, I. U., & Li, K. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1225875 · Cited by 292
Neuroinflammation and Parkinson’s Disease—From Neurodegeneration to Therapeutic Opportunities
Araújo, B., Caridade-Silva, R., Soares-Guedes, C., Martins‐Macedo, J., Gomes, E. D., Monteiro, S., & Teixeira, F. G. (2022) · Cells · doi:10.3390/cells11182908 · Cited by 209
Kalyanaraman, B., Cheng, G., & Hardy, M. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103092 · Cited by 185
Açar, Y., Ağagündüz, D., Cicco, P. D., & Capasso, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115788 · Cited by 134
The gut microbiota–brain axis in neurological disorders
You, M., Chen, N., Yang, Y., Cheng, L., He, H., Cai, Y., Liu, Y., Liu, H., & Hong, G. (2024) · MedComm · doi:10.1002/mco2.656 · Cited by 113
Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis
dos Santos, J. C. C., Lima, M. P. P., Brito, G. A. D. C., & Viana, G. S. D. B. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101812 · Cited by 100
Dong, T. S., & Mayer, E. A. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.024 · Cited by 86
Guo, T.-T., Zhang, Z., Sun, Y., Zhu, R.-Y., Wang, F.-X., Ma, L.-J., Jiang, L., & Liu, H.-D. (2023) · Nutrients · doi:10.3390/nu15040930 · Cited by 82
Mahbub, N. U., Islam, M. M., Hong, S., & Chung, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1348279 · Cited by 90
Review of microbiota gut brain axis and innate immunity in inflammatory and infective diseases
Yuan, C., He, Y., Xie, K., Feng, L., Gao, S., & Cai, L. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1282431 · Cited by 87
dos Santos, J. C. C., Oliveira, L. F., Noleto, F. M., Gusmão, C. T. P., Brito, G. A. D. C., & Viana, G. S. D. B. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.373673 · Cited by 73
Gut microbiota in health and disease: advances and future prospects
Zhang, Y., Wang, H., Sang, Y., Liu, M., Wáng, Q., Yang, H., & Li, X. (2024) · MedComm · doi:10.1002/mco2.70012 · Cited by 67
Microbiota-Derived Tryptophan Metabolite Indole-3-Propionic Acid-Emerging Role in Neuroprotection
Owe-Larsson, M., Drobek, D., Iwaniak, P., Kloc, R., Urbańska, E. M., & Chwil, M. (2025) · Molecules · doi:10.3390/molecules30173628 · Cited by 64
Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
Tanaka, M. (2025) · Cells · doi:10.3390/cells14151161 · Cited by 58
Montanari, M., Imbriani, P., Bonsi, P., Martella, G., & Peppe, A. (2023) · Biomedicines · doi:10.3390/biomedicines11061560 · Cited by 51
Neurotoxic Effects of Pesticides: Implications for Neurodegenerative and Neurobehavioral Disorders
Botnaru, A. A., Lupu, A., Morariu, P. C., Jităreanu, A., Nedelcu, A. H., Morariu, B. A., Anton, E., Gioia, M. L. D., Lupu, V. V., Dragostin, O. M., et al. (2025) · Journal of Xenobiotics · doi:10.3390/jox15030083 · Cited by 57
Jain, A., Madkan, S., & Patil, P. (2023) · Cureus · doi:10.7759/cureus.47861 · Cited by 50
A Narrative Review of Psychobiotics: Probiotics That Influence the Gut–Brain Axis
Ķimse, L., Reinis, A., Miķelsone-Jansone, L., Gintere, S., & Krūmiņa, A. (2024) · Medicina · doi:10.3390/medicina60040601 · Cited by 56
Modulatory effects of traditional Chinese medicines on gut microbiota and the microbiota-gut-x axis
Luo, T., Che, Q., Guo, Z., Song, T., Zhao, J., & Xu, D. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1442854 · Cited by 47
Kurhaluk, N., Kamiński, P., Bilski, R., Kołodziejska, R., Woźniak, A., & Ткаченко, Г. М. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083658 · Cited by 50
Microbiome-based therapies for Parkinson’s disease
Alam, M., Abbas, K., Mustafa, M., Usmani, N., & Habib, S. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1496616 · Cited by 46
Choe, U. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106870 · Cited by 48
Li, Q., Meng, L., Chen, L., Shi, X., Tu, L., Zhou, Q. G., Yu, J.-L., Liao, X., Zeng, Y., & Yuan, Q. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1185375 · Cited by 38
Uceda, S., Echeverry‐Alzate, V., Reiriz, M., Miguel, E. M., Pérez-Curiel, A., Gómez-Senent, S., & Beltrán-Velasco, A. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713294 · Cited by 36
Bashir, Y., & Khan, A. U. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1030694 · Cited by 35
Zali, A., Hajyani, S., Salari, M., Ebrahimi, M. T., Mortazavian, A. M., & Pakpour, B. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06606-9 · Cited by 33
The Impact of Pulmonary Disorders on Neurological Health (Lung-Brain Axis)
Park, H., & Lee, C. H. (2024) · Immune Network · doi:10.4110/in.2024.24.e20 · Cited by 33
Translocation of gut commensal bacteria to the brainPreprint
Thapa, M., Kumari, A. R., Chin, C., Choby, J. E., Jin, F., Bogati, B., Chopyk, D. M., Koduri, N., Pahnke, A. P., Elrod, E. J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.30.555630 · Cited by 31
Qu, Y., An, K., Wang, D., Yu, H., Li, J., Min, Z., Xiong, Y., Xue, Z., & Mao, Z. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04726-7 · Cited by 30
Oral and gut microbial profiling in periodontitis and Parkinson’s disease
Yay, E., Yılmaz, M., Toygar, H. U., Balcı, N., Rivas, C. A., Kılıç, B. B., Zirh, A. T., Paster, B. J., & Kantarcı, A. (2024) · Journal of Oral Microbiology · doi:10.1080/20002297.2024.2331264 · Cited by 29
Mediterranean Diet Adherence, Gut Microbiota and Parkinson’s Disease: A Systematic Review
Seelarbokus, B. A., Menozzi, E., Schapira, A. H. V., Kalea, A. Z., & Macnaughtan, J. (2024) · Nutrients · doi:10.3390/nu16142181 · Cited by 36
Ravi, A., Umapathy, S., & Pan, I. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01609-2 · Cited by 34
Gut microbiota and their influence in brain cancer milieu
BharathwajChetty, B., Kumar, A., Deevi, P. I., Abbas, M., Alqahtani, A., Liang, L., Sethi, G., Liu, L., & Kunnumakkara, A. B. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03434-2 · Cited by 34
Mkilima, T. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15352 · Cited by 30
Yan, X., Shi, L., Zhu, X.-L., Zhao, Y., Luo, J., Li, Q., Xu, Z., & Zhao, J. J. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s531671 · Cited by 28
Self-citationGut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives
Eddin, A. N., Alfuwais, M., Eddin, R. N., AlKattan, K. M., & Yaqinuddin, A. (2024) · Nutrients · doi:10.3390/nu16050590 · Cited by 32
Riegelman, E., Xue, K. S., Wang, J.-S., & Tang, L. (2024) · Nutrients · doi:10.3390/nu16132041 · Cited by 29
Huh, E., Choi, J. G., Choi, Y., Ju, I. G., Kim, B., Shin, Y.-J., An, J. M., Park, M. G., Yim, S. V., Chung, S. J., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104887 · Cited by 24
The link between the gut microbiome, inflammation, and Parkinson’s disease
Nie, S., & Ge, Y. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12789-6 · Cited by 23
Hajjeh, O., Rajab, I. M., Bdair, M., Saife, S., Zahran, A., Nazzal, I., AbuZahra, M. I., Jallad, H., Abukhalil, M. M., Hallak, M., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.015 · Cited by 23
Ugwu, O. P.-C., Okon, M. B., Alum, E. U., Ugwu, C. N., Anyanwu, G. E., Basajja, M., Ogenyi, F. C., Eze, V. H. U., Anyanwu, C. N., Ezeonwumelu, J. O. C., et al. (2025) · Medicine · doi:10.1097/md.0000000000043542 · Cited by 29
Does gut brain axis has an impact on Parkinson’s disease (PD)?
Elangovan, A., Dahiya, B., Kirola, L., Iyer, M., Jeeth, P., Maharaj, S., Kumari, N., Lakhanpal, V., Michel, T. M., Rao, K. R. S. S., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102171 · Cited by 22
Kumar, D., Bishnoi, M., Kondepudi, K. K., & Sharma, S. S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10433-x · Cited by 22
Hong, H., Sloan, L. J., Saxena, D. B., & Scott, D. A. (2022) · Biomedicines · doi:10.3390/biomedicines10081959 · Cited by 20
Parkinson's disease: Are gut microbes involved?
Omotosho, A. O., Tajudeen, Y. A., Oladipo, H. J., Yusuff, S. I., Abdulkadir, M., Muili, A. O., Egbewande, O. M., Yusuf, R. O., Faniran, Z. O., Afolabi, A. O., et al. (2023) · Brain and Behavior · doi:10.1002/brb3.3130 · Cited by 24
Peng, Z., Hou, T., Yang, K., Zhang, J., Mao, Y.-H., & Hou, X. (2025) · Nutrients · doi:10.3390/nu17111769 · Cited by 21
Panaitescu, P.-Ș., Răzniceanu, V., Mocrei-Rebrean, Ș.-M., Neculicioiu, V. S., Dragoș, H.-M., Costache, C. A., & Filip, G. A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050244 · Cited by 20
Kerstens, R., & Joyce, P. (2024) · Biomedicines · doi:10.3390/biomedicines12081738 · Cited by 20
Dog Aging: A Comprehensive Review of Molecular, Cellular, and Physiological Processes
Guelfi, G., Capaccia, C., Tedeschi, M., Bufalari, A., Leonardi, L., Cenci-Goga, B. T., & Maranesi, M. (2024) · Cells · doi:10.3390/cells13242101 · Cited by 22
Sharma, S., Tiwari, N., & Tanwar, S. S. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04069-z · Cited by 24
Nabil, Y., Helal, M. M., Qutob, I. A., Dawoud, A. L. A., Allam, S., Haddad, R., Manasrah, G. M., AlEdani, E. M., Sleibi, W., faris, A., et al. (2025) · BMC Neurology · doi:10.1186/s12883-025-04105-8 · Cited by 21
Ye, M., Yang, J., Li, J., Wang, Y., Chen, W., Zhu, L., Wang, T., Liu, J., Geng, D., & Yu, Z. (2023) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/s44169-023-00034-0 · Cited by 19
Gut Microbiota: An Immersion in Dysbiosis, Associated Pathologies, and Probiotics
Origüela, V., & López-Zaplana, A. (2025) · Microorganisms · doi:10.3390/microorganisms13051084 · Cited by 19
Metabolic modeling links gut microbiota to metabolic markers of Parkinson’s disease
Hensen, T., & Thiele, I. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2554195 · Cited by 16
Xiromerisiou, G., Marogianni, C., Androutsopoulou, A., Ntavaroukas, P., Mysiris, D. S., & Papoutsopoulou, S. (2023) · Biology · doi:10.3390/biology12010093 · Cited by 18
From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson’s Disease Treatment?
Vilela, C., Araújo, B., Soares-Guedes, C., Caridade-Silva, R., Martins‐Macedo, J., Teixeira, C., Gomes, E. D., Prudêncio, C., Vieira, M., & Teixeira, F. G. (2024) · Cells · doi:10.3390/cells13090770 · Cited by 18
Smoking, coffee intake, and Parkinson’s disease: Potential protective mechanisms and components
Hong, S. W., Page, R., & Truman, P. (2024) · NeuroToxicology · doi:10.1016/j.neuro.2024.12.003 · Cited by 16
Hajare, S., & Kulkarni, Y. A. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149975 · Cited by 18
Pourmotabbed, A., Talebi, S., Mehrabani, S., Babaei, A., Khosroshahi, R. A., Bagheri, R., Wong, A., Ghoreishy, S. M., Amirian, P., Zarpoosh, M., et al. (2024) · Nutritional Neuroscience · doi:10.1080/1028415x.2024.2351320 · Cited by 21
Mild cognitive impairment and microbiota: what is known and future perspectives
Gallo, A., Martone, A. M., Liperoti, R., Cipriani, M. C., Ibba, F., Camilli, S., Rognoni, F. M., Landi, F., & Montalto, M. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1410246 · Cited by 15
Nassar, A., Kodi, T., Satarker, S., Gurram, P. C., Fayaz, S. M., & Nampoothiri, M. (2023) · Gene · doi:10.1016/j.gene.2023.147898 · Cited by 15
Singh, I., Anand, S., Gowda, D. J., Kamath, A., & Singh, A. K. (2024) · Biogerontology · doi:10.1007/s10522-024-10128-4 · Cited by 15
Gut Microbiome and Its Role in Parkinson's Disease
Suresh, S. B., Malireddi, A., Abera, M. B., Noor, K., Ansar, M., Boddeti, S., & Nath, T. S. (2024) · Cureus · doi:10.7759/cureus.73150 · Cited by 16
Gut–Brain Axis and Brain Microbiome Interactions from a Medical Perspective
Arneth, B. M. (2025) · Brain Sciences · doi:10.3390/brainsci15020167 · Cited by 17
Parkinson's disease: pathogenesis and therapeutic strategies
Zhang, S., Wang, T., Peng, Y., Wang, Q., Zhang, Z., Shifeng, C. H. U., Huang, H., & Chen, N. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00445-0 · Cited by 13
Yao, L., Yang, Y., Yang, X., & Rezaei, M. J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04151-2 · Cited by 15
The Gut-Brain Axis in Alzheimer’s and Parkinson’s Diseases: The Catalytic Role of Mitochondria
Candeias, E., Pereira-Santos, A. R., Empadinhas, N., Cardoso, S. M., & Esteves, A. R. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240524 · Cited by 16
The microbial guardians: Unveiling the role of gut microbiota in shaping neurodegenerative disease
Izzeddine, N. A., Ahmad, K., Bacha, C., Jabbour, M., Najjar, M., Salhab, S., Ghadieh, H. E., Kanaan, A., Azar, S. T., Khattar, Z. A., et al. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.05.014 · Cited by 19
Zhang, M., Zhai, Z., Yang, B., He, L., Wang, J., Dai, W., Xue, L., Yang, X., Feng, Y., & Wang, H. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1148546 · Cited by 12
Chandel, P., Thapa, K., Kanojia, N., Rani, L., Singh, T. G., & Rohilla, P. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.05.002 · Cited by 13
Thakur, P., Baraskar, K., Shrivastava, V. K., & Medhi, B. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149176 · Cited by 12
Moreno, L. O., Bagüés, A., Martínez, V., & Abalo, R. (2023) · Nutrients · doi:10.3390/nu15122775 · Cited by 11
The Intricate Interplay: Microbial Metabolites and the Gut‐Liver‐Brain Axis in Parkinson's Disease
Kishanchand, D. K., A., A. K. K., Chandrababu, K., Philips, C. A., Sivan, U., & Chakrapani, P. S. B. (2025) · Journal of Neuroscience Research · doi:10.1002/jnr.70016 · Cited by 13
The role of the gut microbiota in neuropsychiatric disorders and therapy
Zhang, F., Ding, K., Zhang, L., Liu, D., Dong, X., Wang, M., Zhou, F.-L., Sun, Y., Zhang, W., Yu, Y., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102894 · Cited by 11
The effects of Nardosinone on levodopa intervention in the treatment of Parkinson's disease
Liu, M., Xue, J., Cao, Y., Hao, Z., Wang, Y., Li, J., Jiang, T., & Shi, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116448 · Cited by 10
Techaniyom, P., Korsirikoon, C., Rungruang, T., Pakaprot, N., Prombutara, P., Mukda, S., Kettawan, A., & Kettawan, A. (2024) · Food Science & Nutrition · doi:10.1002/fsn3.4265 · Cited by 13
Fu, M., Wang, Q., Gao, L., Yuan, X., & Wang, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102387 · Cited by 10
Nagpal, D., Nema, S., Nagpal, S., Pandey, M. M., Kaushik, D. K., & Kathuria, H. (2025) · Antioxidants · doi:10.3390/antiox14091078 · Cited by 13
Gut bacteria-derived metabolites and their implications in mental health and neurological diseases
Srivastava, R., & Gupta, M. K. (2025) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04656-5 · Cited by 10
Gut microbiota and parkinson's disease
Huarcaya, L. R. D., Mohammadi, M. R., & Ríos, M. F. D. (2021) · Cellular Molecular and Biomedical Reports · doi:10.55705/cmbr.2021.410426.1165 · Cited by 7
Microglia and Microbiome-Gut-Brain Axis
Filho, A. M. C., Gomes, N. S., Lós, D. B., Leite, I. B., Tremblay, M., & Macêdo, D. S. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_17 · Cited by 8
Gut microbiota as a potential therapeutic target for children with cerebral palsy and epilepsy
Wu, H., Huang, C., & Xiong, S. (2024) · Brain and Development · doi:10.1016/j.braindev.2024.09.002 · Cited by 9
Zhou, L., Wong, K. Y., & Xie, H. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-024-10163-5 · Cited by 8
Jiang, T., Wang, Y., Fan, W., Lu, Y., Zhang, G., Li, J., Ma, R., Liu, M., & Shi, J. (2025) · BioScience Trends · doi:10.5582/bst.2024.01352 · Cited by 8
Zang, Z., Yang, F., Qu, L., Ge, M., Tong, L., Xue, L., Sun, X., & Hai, Y. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1640389 · Cited by 8
Gao, W., Wu, X., Wang, Y., Lu, F., & Liu, F. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00679 · Cited by 9
Zeng, T., Lin, C., Deng, Y., & Zhu, W. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1371791 · Cited by 7
Gao, A., Lv, J., & Su, Y. (2025) · Brain Sciences · doi:10.3390/brainsci15020159 · Cited by 7
Gut microbiota and Parkinson’s Disease: a new frontier in understanding neurological health
Kumari, N., Addepalli, V., More, A., Patil, A., & Suryawanshi, M. V. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01726-w · Cited by 8
Adaptive immunity in the pathogenesis and treatments of Parkinson’s disease
Du, X., Akter, S., Oludipe, D. B., Sil, S., Zhang, C., Gendelman, H. E., & Mosley, R. L. (2025) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2025-0008 · Cited by 8
Deciphering the microbial map and its implications in the therapeutics of neurodegenerative disorder
Vashishth, S., Ambasta, R. K., & Kumar, P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102466 · Cited by 8
The role of gut-derived short-chain fatty acids in Parkinson's disease
Saadh, M. J., Mustafa, A. N., Mustafa, M. A., Renuka Jyothi, S., Dabis, H. K., Prasad, G. V. S., Mohammad, I. J., Adnan, A., & Idan, A. H. (2024) · Neurogenetics · doi:10.1007/s10048-024-00779-3 · Cited by 9
Chen, W.-L., Deng, F.-S., & Tsai, Y.-C. (2025) · Nutrients · doi:10.3390/nu17193047 · Cited by 8
Age-driven dysbiosis: gut microbiota in the pathogenesis and treatment of aging disorders
Kopalli, S. R., Wankhede, N. L., Rahangdale, S. R., Sammeta, S. S., Aglawe, M. M., Koppula, S., Taksande, B. G., Upaganlawar, A., Umekar, M. J., & Kale, M. B. (2026) · Biogerontology · doi:10.1007/s10522-026-10389-1 · Cited by 6
Uses of Fecal Microbiota Transplantation in Neurodegenerative Disease: A Scoping Review
Sanzone, J., Life, M., Reiss, D., May, D. S., Hartley, B., Spiddle, P., Al-Kirwi, J., Grigoryan, T., & Costin, J. M. (2024) · Cureus · doi:10.7759/cureus.62265 · Cited by 7
Muronets, V. I., Kudryavtseva, S. S., Kurochkina, L. P., Leisi, E. V., Stroylova, Y. Y., & Schmalhausen, E. V. (2025) · Biochemistry (Moscow) · doi:10.1134/s0006297924604003 · Cited by 5
Translocation of bacteria from the gut to the brain in mice
Thapa, M., Kumari, A. R., Chin, C., Choby, J. E., Akbari, E., Bogati, B., Jin, F., Furr, E., Chopyk, D. M., Koduri, N., et al. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003652 · Cited by 37
The Impact of Diet on Parkinson's Disease: A Systematic Review
Anwar, L., Ahmad, E., Imtiaz, M., Ahmad, M. I., Aziz, M. F., & Ibad, T. (2024) · Cureus · doi:10.7759/cureus.70337 · Cited by 6
Chowdhury, M., Chaudhary, N. R., Kaur, P., Goyal, A., & Sahu, S. K. (2024) · Infectious Disorders - Drug Targets · doi:10.2174/0118715265267536231121095634 · Cited by 5
Botti, G., Pavan, B., Bianchi, A., Ferraro, L., Beggiato, S., Brugnoli, F., Bertagnolo, V., & Dalpiaz, A. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106331 · Cited by 5
Metadata
- Authors
- Zhu, M., Liu, X., Ye, Y., Yan, X., Cheng, Y., Zhao, L., Chen, F., & Ling, Z.
- Affiliations
- First Affiliated Hospital Zhejiang University (CN)
- Lishui Central Hospital (CN)
- Corresponding author
- Chen, Feng
- Ling, Zongxin
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2022-06-24
- Volume
- 13
- Pages
- 937555-937555
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC9263276
- OpenAlex
- W4283465314
- Cited by
- 177
- References
- 218
- Citations by year
- 2026: 27 · 2025: 62 · 2024: 61 · 2023: 22 · 2022: 4
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (2019BINCMCF045, tsqn202103119, 31700800, JNL-2022033C, 81790631, LGF20H090016, 81771724, 2018YFC2000500, 2022C03060)
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases
- Basic Public Welfare Research Program of Zhejiang Province (81790631, 31700800, 2019BINCMCF045, JNL-2022033C, LGF20H090016, 2022C03060, tsqn202103119, 2018YFC2000500, 81771724)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Parkinson's disease, gut microbiota, gut dysbiosis, intestinal permeability, neuroinflammation, alpha-synuclein aggregation, oxidative stress, neurotransmitter production, probiotics, psychobiotics, prebiotics, synbiotics, postbiotics, fecal microbiota transplantation, diet, traditional Chinese medicine, therapeutic target
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Animals, Parkinson Disease, Neurodegenerative Diseases, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
